CARB 85-Development of glycomic and glycoproteomic tools for cancer biomarker discovery

被引:0
|
作者
Mechref, Yehia [1 ]
Novotny, Milos V. [1 ]
Alley, William R. [1 ]
Kyselova, Zuzana [1 ]
Milan, Madera [1 ]
Mann, Benjamin [1 ]
Klouckova, Iveta [1 ]
Goetz, John A. [1 ]
Hussein, Ahmed [1 ]
Kang, Pilsoo [1 ]
机构
[1] Indiana Univ, Bloomington, IN 47405 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
85-CARB
引用
收藏
页数:1
相关论文
共 39 条
  • [31] Biomarker assay translation from discovery to clinical studies in cancer drug development: Quantification of emerging protein biomarkers
    Lee, Jean W.
    Figeys, Daniel
    Vasilescu, Julian
    ADVANCES IN CANCER RESEARCH, VOL 96, 2007, 96 : 269 - 298
  • [32] Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer
    Lu, Yiling
    Ling, Shiyun
    Hegde, Apurva M.
    Byers, Lauren A.
    Coombes, Kevin
    Mills, Gordon B.
    Akbani, Rehan
    SEMINARS IN ONCOLOGY, 2016, 43 (04) : 476 - 483
  • [33] Biomarker-guided development of novel multi-peptide cancer vaccines - from discovery to phase III trials.
    Singh-Jasuja, Harpreet
    Walter, Steffen
    Weinschenk, Toni
    Kirner, Alexandra
    Mayer-Mokler, Andrea
    Hilf, Norbert
    Schoor, Oliver
    Dietrich, Pierre-Yves
    Richtie, James
    Rampling, Roy
    Mayer, Frank
    Stenzl, Arnulf
    Rini, Brian
    Reinhardt, Carsten
    Rammensee, Hans-Georg
    CANCER RESEARCH, 2013, 73 (08)
  • [34] Impact of Gene Biomarker Discovery Tools Based on Protein–Protein Interaction and Machine Learning on Performance of Artificial Intelligence Models in Predicting Clinical Stages of Breast Cancer
    Elham Amjad
    Solmaz Asnaashari
    Babak Sokouti
    Siavoush Dastmalchi
    Interdisciplinary Sciences: Computational Life Sciences, 2020, 12 : 476 - 486
  • [35] Biomarker-Driven Drug Discovery in Cancer-Trastuzumab Development 2019 Lasker-DeBakey Clinical Medical Research Award
    Shepard, H. Michael
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (13): : 1249 - 1250
  • [36] Impact of Gene Biomarker Discovery Tools Based on Protein-Protein Interaction and Machine Learning on Performance of Artificial Intelligence Models in Predicting Clinical Stages of Breast Cancer
    Amjad, Elham
    Asnaashari, Solmaz
    Sokouti, Babak
    Dastmalchi, Siavoush
    INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES, 2020, 12 (04) : 476 - 486
  • [37] Biomarker discovery and development of prognostic prediction model using metabolomic panel in breast cancer patients: a hybrid methodology integrating machine learning and explainable artificial intelligence
    Yagin, Fatma Hilal
    Gormez, Yasin
    Al-Hashem, Fahaid
    Ahmad, Irshad
    Ahmad, Fuzail
    Ardigo, Luca Paolo
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
  • [38] Development of a Universal Metabolome-Standard Method for Long-Term LC-MS Metabolome Profiling and Its Application for Bladder Cancer Urine-Metabolite-Biomarker Discovery
    Peng, Jun
    Chen, Yi-Ting
    Chen, Chien-Lun
    Li, Liang
    ANALYTICAL CHEMISTRY, 2014, 86 (13) : 6540 - 6547
  • [39] Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery
    Li, Xian
    Wen, Xinxin
    Luo, Zewei
    Tian, Yonghui
    Qian, Cheng
    Zhang, Jing
    Ling, Rui
    Duan, Yixiang
    CLINICA CHIMICA ACTA, 2023, 540